Capital Markets Days

Available information

• Agenda
• News Release
  

Presentations

• Supporting slides: PDF
  

Available information

• Agenda
• News Release
  

Presentations

• Supporting slides: PDF
  

Available information

• Agenda
• News Release

Presentations

• Stefan Oschmann: Focus on value creation
• Marcus Kuhnert: Proof of value creation
  

Available information

• Agenda

Presentations

• Karl-Ludwig Kley: The Journey of Merck KGaA, Darmstadt, Germany 2007 - 2015
• Stefan Oschmann: Deliver on Growth
• Marcus Kuhnert: Financial Perpectives 
  

Available information

• Stefan Oschmann, CEO Pharma: Introduction
• Belen Garijo, President & CEO of EMD Serono: Introduction
• Marcus Kuhnert, CFO: Introduction

Presentations

• Karl-Ludwig Kley: Strategic perspective on Merck KGaA, Darmstadt, Germany
• Stefan Oschmann: Taking EMD Serono to the next level of value generation
• Belen Garijo: Roadmap to sustainable success
• Luciano Rossetti: A first take on R&D at EMD Serono
• Harsukh Parmar: Immunology - from symptom relief to disease modification
• Andrew Schiermeier/Andree Blaukat: Oncology - building on our established strengths
• Helen Sabzevari: ImmunoOncology - cancer therapy powered by the immune system
• Simon Sturge: Biosimilars - a compelling fit for Merck KGaA, Darmstadt, Germany
• Marcus Kuhnert: Merck KGaA, Darmstadt, Germany - financial perspective on value creation

Presentations

• Dr. Bernd Reckmann, Member of the Executive Board: Leadership built on unique strengths
• Walter Galinat, President of Performance Materials: Characteristics of the liquid crystals market
• Michael Heckmeier, Senior Vice President LC: Shaping the future of liquid crystals
• Udo Heider, Vice President OLED: OLED and respective position of Merck KGaA, Darmstadt, Germany
• Thomas Kietzke, Director Strategy and Market Intelligence: LCDs – a high hurdle for new large display technologies
• Matthias Zachert, CFO: Liquid Crystals - sustained value contribution
  

• Dr. Bernd Reckmann, Member of the Executive Board
• Robert Yates, Head of EMD Millipore
• Matthias Zachert, CFO
• Breakout Session: Process Solutions
• Breakout Session: Bioscience Solutions
• Breakout Session: Lab Solutions

Presentations

• Karl-Ludwig Kley, Chairman of the Executive Board
• Stefan Oschmann, Member of the Executive Board & Head of Pharma
• Matthias Zachert, Member of the Executive Board & CFO
• Annalisa Jenkins (EMD Serono), Head of Global Drug Development & Medical
• Belen Garijo (EMD Serono), Chief Operating Officer
• Bharat Tewarie (EMD Serono), Head of Business Franchise Neurodegenerative Diseases